InvestorsHub Logo
Followers 71
Posts 11465
Boards Moderated 0
Alias Born 12/25/2009

Re: DewDiligence post# 379

Thursday, 01/05/2017 8:34:44 AM

Thursday, January 05, 2017 8:34:44 AM

Post# of 1163
Suppose the time of the information had something to do with it (2:15 pm). The drug symbols (LABU my choice for gauging) were already bullish and they retained approx the same level till close. Also it was probably unnoticed unless one follows The Fly and/or Politico. Didn't cause me to sell but it could be a harbinger. Trump has already expressed concern about drug pricing and later in the day Biden was quoted as concerned about pricing:

"Now, Biden said, he is getting strong encouragement from throughout the cancer community to grapple with the pricing issue. “The researchers, the insurers, all of the major cancer centers .?.?. want me to pursue it.” He added that Greg Simon, executive director of the White House Moonshot Task Force, recently met with the pharmaceutical company officials. “They all realize they have a problem,” the vice president said.

In December, President-elect Donald Trump also spoke out against pharmaceutical-industry price hikes. “I'm going to bring down drug prices,” he told Time magazine."
__________________________________________
https://www.washingtonpost.com/news/to-your-health/wp/2017/01/04/biden-to-tackle-cancer-drug-prices-as-part-of-post-white-house-moonshot-work/?postshare=2401483574234825&tid=ss_tw&utm_term=.3aa478a6880c

Is BMY among those who should be targeted for abusive pricing? I wasn't aware it has been.

BMY
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BMY News